Atiq OT - Search Results

1

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.

Atiq OT, Kemeny N, Niedzwiecki D, Botet J. Atiq OT, et al. Cancer. 1992 Feb 15;69(4):920-4. doi: 10.1002/1097-0142(19920215)69:4<920::aid-cncr2820690414>3.0.co;2-y. Cancer. 1992. PMID: 1370918

2

Non-surgical treatment for liver metastases.

Kemeny NE, Atiq OT. Kemeny NE, et al. Among authors: atiq ot. Baillieres Best Pract Res Clin Gastroenterol. 1999 Dec;13(4):593-610. doi: 10.1053/bega.1999.0050. Baillieres Best Pract Res Clin Gastroenterol. 1999. PMID: 10654922 Review.

3

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

Kelsen D, Atiq OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale C, Vinciguerra V, Brennan M. Kelsen D, et al. Among authors: atiq ot. J Clin Oncol. 1992 Apr;10(4):541-8. doi: 10.1200/JCO.1992.10.4.541. J Clin Oncol. 1992. PMID: 1548519 Clinical Trial.

4

Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.

Atiq OT, Kelsen DP, Shiu MH, Saltz L, Tong W, Niedzwiecki D, Trochanowski B, Lin S, Toomasi F, Brennan M. Atiq OT, et al. J Clin Oncol. 1993 Mar;11(3):425-33. doi: 10.1200/JCO.1993.11.3.425. J Clin Oncol. 1993. PMID: 8445416 Clinical Trial.

5

Therapy of upper gastrointestinal tract cancers.

Kelsen D, Atiq OT. Kelsen D, et al. Among authors: atiq ot. Curr Probl Cancer. 1991 Sep-Oct;15(5):235-94. Curr Probl Cancer. 1991. PMID: 1743044 Review.

6

Haemodynamic effects of recombinant interleukin-2 administered by constant infusion.

Groeger JS, Bajorin D, Reichman B, Kopec I, Atiq O, Pierri MK. Groeger JS, et al. Eur J Cancer. 1991;27(12):1613-6. doi: 10.1016/0277-5379(91)90426-e. Eur J Cancer. 1991. PMID: 1782070

7

Cutaneous T-cell lymphoma presenting with diffuse lymphomatous infiltration of the peripheral nerves: response to combination chemotherapy.

Atiq OT, DeAngelis LM, Rosenblum M, Portlock CS. Atiq OT, et al. Am J Clin Oncol. 1992 Jun;15(3):212-5. doi: 10.1097/00000421-199206000-00006. Am J Clin Oncol. 1992. PMID: 1375431

8

The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer.

Atiq SO, Atiq OO, Atiq MO, Phillips KC, Jacks BB, Moreno M, Maraboyina S, Atiq OT. Atiq SO, et al. Among authors: atiq ot. Am J Case Rep. 2018 Oct 18;19:1241-1244. doi: 10.12659/AJCR.910224. Am J Case Rep. 2018. PMID: 30333474 Free PMC article.

9

Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study.

Kozuch PS, Rocha-Lima CM, Dragovich T, Hochster H, O'Neil BH, Atiq OT, Pipas JM, Ryan DP, Lenz HJ. Kozuch PS, et al. Among authors: atiq ot. J Clin Oncol. 2008 May 10;26(14):2320-6. doi: 10.1200/JCO.2007.14.0152. J Clin Oncol. 2008. PMID: 18467723 Clinical Trial.

10

Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial.

Adkins D, Ley J, Atiq O, Powell S, Spanos WC, Gitau M, Rigden C, Palka K, Liu J, Oppelt P. Adkins D, et al. Oral Oncol. 2021 Apr;115:105173. doi: 10.1016/j.oraloncology.2020.105173. Epub 2021 Feb 3. Oral Oncol. 2021. PMID: 33548860 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters